Authorizes use of healthcare platforms providing discounted prices for payment of prescription and non-prescription drugs or devices and for telehealth and telemedicine services.
Impact
The bill will impact existing state laws regarding how pharmacy benefits managers operate with private health insurers and state health benefit programs. Specifically, it prohibits pharmacy benefits managers from requiring any copayment or payment that exceeds the direct purchase price of a prescription drug. This change is expected to foster a more competitive market for drug pricing, ultimately benefiting consumers by improving their options while ensuring that they pay no more than non-insured patients would for the same medications.
Summary
Assembly Bill A5212 authorizes the use of healthcare platforms that provide discounted prices for payment of prescription and non-prescription drugs and devices, as well as for telehealth and telemedicine services. This piece of legislation aims to enhance accessibility to affordable healthcare options for users who may or may not possess separate health insurance coverage, thereby encouraging greater utilization of health services and medications at lower costs.
Sentiment
The sentiment around A5212 appears supportive among advocates for lower drug prices and better access to health services. Proponents argue that the bill is a significant step towards reducing out-of-pocket costs for consumers. However, some stakeholders express caution, fearing that while the intent is beneficial, the broader implications of allowing discounts through healthcare platforms might complicate the healthcare pricing landscape and disrupt standard practices.
Contention
Notable points of contention surrounding the bill involve the mechanisms of enforcement and potential ramifications for pharmacy benefits managers. Concerns have been raised regarding the balance of power between large insurers and local pharmacies in disclosing pricing options to consumers. Stakeholders worry that the shift to allowing discounted prices mediated through healthcare platforms could unintentionally limit pharmacy manager profits or alter existing contractual arrangements, leading to further adjustments in the healthcare delivery system.
Same As
Authorizes use of healthcare platforms providing discounted prices for payment of prescription and non-prescription drugs or devices and for telehealth and telemedicine services.
Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.